ENVESTNET ASSET MANAGEMENT INC - VALLON PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

VALLON PHARMACEUTICALS INC's ticker is VLON and the CUSIP is 92023M101. A total of 12 filers reported holding VALLON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of VALLON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$110,000
-10.6%
18,465
+9.4%
0.00%–
Q3 2021$123,000
+29.5%
16,873
-3.7%
0.00%–
Q2 2021$95,000
+72.7%
17,513
+48.7%
0.00%–
Q1 2021$55,000–11,776–0.00%–
 Download
Other shareholders
VALLON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
WELLS FARGO & COMPANY/MN 15$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 21,569$13,0000.00%
CITIGROUP INC 6,000$4,0000.00%
North Star Investment Management Corp. 1,750$1,0000.00%
MORGAN STANLEY 50$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 35,798$23,0000.00%
Tower Research Capital LLC (TRC) 12,040$8,0000.00%
Renaissance Technologies 78,888$50,0000.00%
VANGUARD GROUP INC 23,464$15,0000.00%
View complete list of VALLON PHARMACEUTICALS INC shareholders